Ozanimod
Product Detail
Product Tags
| Pack Size | Availability | Pretium (USD) |
| 1g | In Stock | 200 |
| 5g | In Stock | 800 |
| 10g | In Stock | 1200 |
| Plus Sizes | Get Quotes | Get Quotes |
Nomen chemicum:
(S) -5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2 -isopropoxybenzonitrile
SMILES Code:
N#CC1=CC(C2=NC(C3=CC=CC4=C3CC[C@@H]4NCCO)=NO2)=CC=C1OC(C)C
InChi Code:
InChI=1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3- 4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1- 2H3/t20-/m0/s1
InChi Key:
XRVDGNKRPOAQTN-FQEVSTJZSA-N
Keyword:
Ozanimod, RPC-1063, RPC1063, RPC 1063, 1306760-87-1
Solubilitas:Solutum in DMSO
Repono:0 - 4°C ad terminum brevem (dies ad septimanas), vel -20°C ad terminum longi (menses).
Descriptio:
Ozanimod modulator sphingosine-1-phosphatis (S1P) receptorum S1P1 et SIP5 modulator ore promptus est. Internum S1P1 inducit, B et CCR7 (+) T lymphocytes circumferens decrescit, et inflammationem et morbum parametri in tres morbos autoimmunes exempla reducit.1 Ozanimod in iudiciis clinicis est recidivus multiplex sclerosis et ulcerativis colitis.
Target: S1P
